About Technology Issues FAQ

Links

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer — Distribution of the number of citations over years.

EXALY

Terms of Service

Profiles

Online Resources

Software Packages

Fields

Search Engines

Advanced Search

Chemicals Search

Tools

Reference Formatting

Research Trends

site/software © exaly; All materials licenced under CC by-SA.